Filing Details
- Accession Number:
- 0001144204-17-022289
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-04-26 16:30:40
- Reporting Period:
- 2017-04-25
- Filing Date:
- 2017-04-26
- Accepted Time:
- 2017-04-26 16:30:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1659617 | Moleculin Biotech Inc. | MBRX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1545414 | P. Jonathan Foster | C/O Moleculin Biotech, Inc. 2575 West Bellfort, Suite 333 Houston TX 77054 | Exec. Vice President & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-04-25 | 10,000 | $0.86 | 10,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
